Article
Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis
13 Jan 2023
Abstract excerpt
Background: Glioma is the most common primary tumor of the central nervous system. The conventional glioma treatment strategies include surgical excision and chemo- and radiation-therapy. Interferon Gamma (IFN-γ) is a soluble dimer cytokine involved in immune escape of gliomas. In this study, we sought to identify IFN-γ-related genes to construct a glioma prognostic model to guide its clinical treatment. Methods:...
Topics
Join the communities discussing this publication.
